In a study published in the journal Medical Care, authors identify improved outcomes following acute events among enrollees in the STAR+PLUS program.
Expansion of a new healthcare program in Texas that covers disabled adults on Medicaid has seen improved outcomes in those suffering from chronic pulmonary obstructive disease (COPD) or those who have had a heart attack.
The STAR+PLUS Medicaid managed care program that was evaluated in the study is a home and community-based service (HCBS). Formulated by Medicaid, HCBS programs cater to specific targeted populations and are an alternative to institutional care. In the current study, published in Medical Care, the authors compared quality of care rendered before and after a mandatory transition of disabled Medicaid enrollees (over 21 years old), from fee-for-service (FFS) or primary care case management (PCCM) to STAR+PLUS. Results were compared with the outcomes of enrollees who remained in FFS or PCCM models. Data were collected from 28 counties in Texas.
For the 6 quality measures that were evaluated, the authors found that STAR+PLUS enrollees adhered better to the use of β-blockers after discharge following a heart attack (81% adherence posttransition, compared with 49% in the control sample). Similar results were observed in COPD patients—68% adherence to use of systemic corticosteroids and bronchodilators following an event, compared with 39% adherence observed in the control FFS or PCCM population. However, the authors did not observe any difference in routine aspects of care for chronic conditions between the new care delivery model and the traditional model.
The authors attribute the positive results to rigorous and integrated follow-up following an acute event in the managed care program.
"As more and more states look to adopt this model, it is crucial that we examine whether vulnerable populations, like disabled adults, are receiving the type of high-quality care that will promote their health and well-being," said Elizabeth A. Shenkman, PhD, chair of the department of health outcomes and policy in the UF College of Medicine and coauthor of the study, in a statement.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More